Friday, December 23, 2016

BRIEF-Vectura signs deal with Mundipharma on respiratory treatments

* Global development programme with Mundipharma for PMDI

inhaled triple therapy (VR2076) for asthma and COPD

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)